Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Micke

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Scientific Reports|September 21, 2016
Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitisMasafumi Horie, Yoko Yamaguchi, Akira Saito, et al.
International Journal of Cancer|April 9, 2014
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerPatrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.
Translational Lung Cancer Research|January 13, 2023
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomasViktoria Thurfjell, Patrick Micke, Hui Yu, et al.
Histopathology|December 17, 2013
A systematic analysis of commonly used antibodies in cancer diagnosticsGabriela Gremel, Julia Bergman, Dijana Djureinovic, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2021
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lungTorsten Goldmann, Sebastian Marwitz, Dörte Nitschkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2014
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancerSatoshi Noguchi, Akira Saito, Masafumi Horie, et al.
Cancer Letters|December 3, 2014
Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expressionJohanna S M Mattsson, Bengt Bergman, Marianna Grinberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2011
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancerPatrick Micke, Karolina Edlund, Lars Holmberg, et al.
Nature Communications|November 14, 2025
scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samplesRam Prakash Yadav, Pengwei Xing, Miao Zhao, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Scientific Reports|September 21, 2016
Transcriptome analysis of periodontitis-associated fibroblasts by CAGE sequencing identified DLX5 and RUNX2 long variant as novel regulators involved in periodontitisMasafumi Horie, Yoko Yamaguchi, Akira Saito, et al.
International Journal of Cancer|April 9, 2014
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerPatrick Micke, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.
Translational Lung Cancer Research|January 13, 2023
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomasViktoria Thurfjell, Patrick Micke, Hui Yu, et al.
Histopathology|December 17, 2013
A systematic analysis of commonly used antibodies in cancer diagnosticsGabriela Gremel, Julia Bergman, Dijana Djureinovic, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2021
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lungTorsten Goldmann, Sebastian Marwitz, Dörte Nitschkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2014
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancerSatoshi Noguchi, Akira Saito, Masafumi Horie, et al.
Cancer Letters|December 3, 2014
Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expressionJohanna S M Mattsson, Bengt Bergman, Marianna Grinberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2011
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancerPatrick Micke, Karolina Edlund, Lars Holmberg, et al.
Nature Communications|November 14, 2025
scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samplesRam Prakash Yadav, Pengwei Xing, Miao Zhao, et al.
Pageof 17